Garnero P - Search Results

1

Is bone quality associated with collagen age?

Leeming DJ, Henriksen K, Byrjalsen I, Qvist P, Madsen SH, Garnero P, Karsdal MA. Leeming DJ, et al. Among authors: garnero p. Osteoporos Int. 2009 Sep;20(9):1461-70. doi: 10.1007/s00198-009-0904-3. Epub 2009 Mar 28. Osteoporos Int. 2009. PMID: 19330423 Review.

2

Measurement of bone degradation products in serum using antibodies reactive with an isomerized form of an 8 amino acid sequence of the C-telopeptide of type I collagen.

Bonde M, Garnero P, Fledelius C, Qvist P, Delmas PD, Christiansen C. Bonde M, et al. Among authors: garnero p. J Bone Miner Res. 1997 Jul;12(7):1028-34. doi: 10.1359/jbmr.1997.12.7.1028. J Bone Miner Res. 1997. PMID: 9200001 Free article.

3

The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation.

Garnero P, Ferreras M, Karsdal MA, Nicamhlaoibh R, Risteli J, Borel O, Qvist P, Delmas PD, Foged NT, Delaissé JM. Garnero P, et al. J Bone Miner Res. 2003 May;18(5):859-67. doi: 10.1359/jbmr.2003.18.5.859. J Bone Miner Res. 2003. PMID: 12733725 Free article.

4

Identification of progressors in osteoarthritis by combining biochemical and MRI-based markers.

Dam EB, Loog M, Christiansen C, Byrjalsen I, Folkesson J, Nielsen M, Qazi AA, Pettersen PC, Garnero P, Karsdal MA. Dam EB, et al. Among authors: garnero p. Arthritis Res Ther. 2009;11(4):R115. doi: 10.1186/ar2774. Epub 2009 Jul 24. Arthritis Res Ther. 2009. PMID: 19630944 Free PMC article.

5

Type I collagen racemization and isomerization and the risk of fracture in postmenopausal women: the OFELY prospective study.

Garnero P, Cloos P, Sornay-Rendu E, Qvist P, Delmas PD. Garnero P, et al. J Bone Miner Res. 2002 May;17(5):826-33. doi: 10.1359/jbmr.2002.17.5.826. J Bone Miner Res. 2002. PMID: 12009013 Free article.

6

The role of collagen in bone strength.

Viguet-Carrin S, Garnero P, Delmas PD. Viguet-Carrin S, et al. Among authors: garnero p. Osteoporos Int. 2006;17(3):319-36. doi: 10.1007/s00198-005-2035-9. Epub 2005 Dec 9. Osteoporos Int. 2006. PMID: 16341622 Review.

7

Collagen type II C-telopeptide fragments as an index of cartilage degradation.

Christgau S, Garnero P, Fledelius C, Moniz C, Ensig M, Gineyts E, Rosenquist C, Qvist P. Christgau S, et al. Among authors: garnero p. Bone. 2001 Sep;29(3):209-15. doi: 10.1016/s8756-3282(01)00504-x. Bone. 2001. PMID: 11557363

8

Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY study.

Garnero P, Sornay-Rendu E, Munoz F, Borel O, Chapurlat RD. Garnero P, et al. Osteoporos Int. 2013 Feb;24(2):489-94. doi: 10.1007/s00198-012-1978-x. Epub 2012 Apr 14. Osteoporos Int. 2013. PMID: 22525978

9

Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards.

Vasikaran S, Eastell R, Bruyère O, Foldes AJ, Garnero P, Griesmacher A, McClung M, Morris HA, Silverman S, Trenti T, Wahl DA, Cooper C, Kanis JA; IOF-IFCC Bone Marker Standards Working Group. Vasikaran S, et al. Among authors: garnero p. Osteoporos Int. 2011 Feb;22(2):391-420. doi: 10.1007/s00198-010-1501-1. Epub 2010 Dec 24. Osteoporos Int. 2011. PMID: 21184054 Review.

10

Treatment of postmenopausal women with osteoporosis or low bone density with raloxifene. Raloxifene Study Group.

Meunier PJ, Vignot E, Garnero P, Confavreux E, Paris E, Liu-Leage S, Sarkar S, Liu T, Wong M, Draper MW. Meunier PJ, et al. Among authors: garnero p. Osteoporos Int. 1999;10(4):330-6. doi: 10.1007/s001980050236. Osteoporos Int. 1999. PMID: 10692984 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

287 results

Search Page

Filters